Compositions and method for treatment of cancer using...

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

167/140

C12N 5/12 (2006.01) A61K 38/20 (2006.01) A61K 39/395 (2006.01) A61P 35/00 (2006.01)

Patent

CA 1341374

Cell surface gangliosides are presumed to play a role in cell growth and differentiation. Using monoclonal antibodies directed against G D3, a disialoganglioside expressed predominantly by cells of neuroectodermal origin, we have found that G D3 is expressed by a subpopulation of cells of the immune system including: a) fetal thymocytes in subcortical regions and near vessels, 2) lymph node lymphocytes in interfollicular areas and near vessels, and 3) a small subset of T cells in the peripheral blood. Mouse monoclonal antibodies (two IgGs, one IgM and F(ab')2 fragments) reacting with G D3 were found to stimulate proliferation of T cells derived from peripheral blood. Proliferation induced by binding to G D3 could be augmented by exogenous IL-2, PMA, PHA or Protein A.

551669

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Compositions and method for treatment of cancer using... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compositions and method for treatment of cancer using..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and method for treatment of cancer using... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1182104

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.